Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium.

Helbing T, Rothweiler R, Ketterer E, Goetz L, Heinke J, Grundmann S, Duerschmied D, Patterson C, Bode C, Moser M.

Blood. 2011 Nov 3;118(18):5040-9. doi: 10.1182/blood-2011-03-339762. Epub 2011 Sep 7.


Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.

Pi X, Lockyer P, Dyer LA, Schisler JC, Russell B, Carey S, Sweet DT, Chen Z, Tzima E, Willis MS, Homeister JW, Moser M, Patterson C.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2214-22. doi: 10.1161/ATVBAHA.112.252015. Epub 2012 Jul 5.


BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.

Heinke J, Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T, Laib A, Augustin H, Bode C, Patterson C, Moser M.

Circ Res. 2008 Oct 10;103(8):804-12. doi: 10.1161/CIRCRESAHA.108.178434. Epub 2008 Sep 11.


BMPER is upregulated by statins and modulates endothelial inflammation by intercellular adhesion molecule-1.

Helbing T, Rothweiler R, Heinke J, Goetz L, Diehl P, Zirlik A, Patterson C, Bode C, Moser M.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):554-60. doi: 10.1161/ATVBAHA.109.201087. Epub 2009 Dec 30.


Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation.

Heinke J, Juschkat M, Charlet A, Mnich L, Helbing T, Bode C, Patterson C, Moser M.

J Cell Sci. 2013 Jul 15;126(Pt 14):3082-94. doi: 10.1242/jcs.122333. Epub 2013 May 2.


Kruppel-like factor 4 regulates endothelial inflammation.

Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, Feinberg MW, Gerzsten RE, Edelman ER, Jain MK.

J Biol Chem. 2007 May 4;282(18):13769-79. Epub 2007 Mar 5.


BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation.

Moser M, Binder O, Wu Y, Aitsebaomo J, Ren R, Bode C, Bautch VL, Conlon FL, Patterson C.

Mol Cell Biol. 2003 Aug;23(16):5664-79.


BMPER-induced BMP signaling promotes coronary artery remodeling.

Dyer L, Wu Y, Moser M, Patterson C.

Dev Biol. 2014 Feb 15;386(2):385-94. doi: 10.1016/j.ydbio.2013.12.019. Epub 2013 Dec 27.


Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.

Csiszar A, Ahmad M, Smith KE, Labinskyy N, Gao Q, Kaley G, Edwards JG, Wolin MS, Ungvari Z.

Am J Pathol. 2006 Feb;168(2):629-38.


Inhibition of BMP activity protects epithelial barrier function in lung injury.

Helbing T, Herold EM, Hornstein A, Wintrich S, Heinke J, Grundmann S, Patterson C, Bode C, Moser M.

J Pathol. 2013 Sep;231(1):105-16. doi: 10.1002/path.4215. Epub 2013 Jul 10.


Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.

Esser JS, Rahner S, Deckler M, Bode C, Patterson C, Moser M.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):358-67. doi: 10.1161/ATVBAHA.114.304345. Epub 2014 Dec 11.


ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration.

Hortelano S, López-Fontal R, Través PG, Villa N, Grashoff C, Boscá L, Luque A.

Cardiovasc Res. 2010 May 1;86(2):283-92. doi: 10.1093/cvr/cvq050. Epub 2010 Feb 17.


Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy.

Moreno-Miralles I, Ren R, Moser M, Hartnett ME, Patterson C.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2216-22. doi: 10.1161/ATVBAHA.111.230235. Epub 2011 Jul 7.


VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S.

Gastroenterology. 2009 Feb;136(2):585-95.e5. doi: 10.1053/j.gastro.2008.09.064. Epub 2008 Oct 7.


A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling.

Kelley R, Ren R, Pi X, Wu Y, Moreno I, Willis M, Moser M, Ross M, Podkowa M, Attisano L, Patterson C.

J Cell Biol. 2009 Feb 23;184(4):597-609. doi: 10.1083/jcb.200808064. Epub 2009 Feb 16.


Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.

Boström KI, Jumabay M, Matveyenko A, Nicholas SB, Yao Y.

Circ Res. 2011 Feb 18;108(4):446-57. doi: 10.1161/CIRCRESAHA.110.236596. Epub 2010 Dec 30.


Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells.

Csiszar A, Labinskyy N, Jo H, Ballabh P, Ungvari Z.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H569-77. doi: 10.1152/ajpheart.00180.2008. Epub 2008 Jun 6.


Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.

Heinke J, Kerber M, Rahner S, Mnich L, Lassmann S, Helbing T, Werner M, Patterson C, Bode C, Moser M.

Oncogene. 2012 Jun 14;31(24):2919-30. doi: 10.1038/onc.2011.473. Epub 2011 Oct 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk